ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Viviana Pinzón-Ramírez, Luis E Cueva-Cañola, Dilmareth E Natera, Helder Edgar Aldo-Chávez Olivera, Oscar Eduardo Camacho-Hernández, Andrea C Beltran-De la Fuente, Sergio Alexis Ramirez-Alvarez, Einstein Yhair Gallardo Cubas, Giomar Vilca Flores, Mauricio E Gamez, Leonardo Rangel Castilla
Pragyat Thakur, Nagarjun Ballari, Anureet Kaur, Tapas Kumar Dora, I Vedamanasa, Arshdeep Kaur, Ashish Gulia
Adnan-Mustafiz Chowdhury, Sattam A Halaseh, Debora Joseph, Abel I Abel, Nikita Jha, Amro Al-Karadsheh, Hakam Al-Karadsheh, Omar A Salem, Sama F Salaitah, Noor M Arman, Georges Rizkallah